Inventor

Karl-Heinz Schlemmer

Inventor

Wuppertal, DE

Overview

2001–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 115 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%

C07DHeterocyclic compounds34%

A61KPreparations for medical, dental or toiletry purposes19%

C07CAcyclic or carbocyclic compounds5%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%

C07BGeneral methods of organic chemistry1%

A01NPreservation of bodies of humans or animals or plants or parts thereof0%

PatentTitleYear

10,736,896Substituted 5-fluoro-1H-pyrazolopyridines and their use2020 10,668,071(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use2020 10,414,731Substituted oxopyridine derivatives2019 10,259,776Branched 3-phenylpropionic acid derivatives and their use2019 10,183,932Substituted oxopyridine derivatives and use thereof cardiovascular disorders2019 10,167,280Substituted oxopyridine derivatives2019 10,138,236Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives2018 10,118,930Piperidinylpyrazolopyrimidinones and their use2018 10,098,883(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use2018 10,077,265Substituted oxopyridine derivatives2018 10,071,995Substituted oxopyridine derivatives2018 10,023,528Branched 3-phenylpropionic acid derivatives and their use2018 9,993,476Substituted 5-flouro-1H-pyrazolopyridines and their use2018 9,918,969'Substituted oxopyridine derivatives and use thereof as factor XIa/plasma'2018 9,822,102'Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders'2017 9,765,070'Substituted oxopyridine derivatives'2017 9,598,417'(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use'2017 9,475,809'Substituted oxopyridine derivatives and use thereof as factor xia/plasma'2016 9,434,690'Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders'2016 9,387,203'Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof'2016 9,309,239'Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereof'2016 9,309,198'N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase'2016 9,266,885'Substituted 5-fluoro-1H-pyrazolopyridines and their use'2016 9,051,316'Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use'2015 9,040,691'Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors'2015 9,018,414'Substituted 3-phenylpropionic acids and the use thereof'2015 9,018,258'Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof'2015 8,987,256'Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof'2015 8,921,377'Substituted 5-fluoro-1H-pyrazolopyridines and their use'2014 8,822,458'Substituted oxazolidinones and their use in the field of blood coagulation'2014 8,796,335'Branched 3-phenylpropionic acid derivatives and their use'2014 8,691,850'Substituted phenylaminothiazoles and use thereof'2014 8,673,903'Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof'2014 8,642,592'Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof'2014 8,609,727'Dicarboxylic acid derivatives and their use'2013 8,530,505'Substituted oxazolidinones and their use in the field of blood coagulation'2013 8,524,722'Substituted tricyclic compounds and methods of use thereof'2013 8,436,180'Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof'2013 8,420,656'Substituted 5-fluoro-1H-pyrazolopyridines and their use'2013 8,404,723'3-cyano 5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases'2013 8,404,709'Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof'2013 8,399,471'Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the same'2013 8,362,015'Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders'2013 8,343,987'Heterocyclic derivatives'2013 8,334,284'Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders'2012 8,324,222'Cyclically substituted furopyrimidine derivatives and use thereof'2012 8,309,551'Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders'2012 8,217,063'Lactam-substituted dicarboxylic acids and use thereof'2012 8,183,246'Acyclically substituted furopyrimidine derivatives and use thereof'2012 8,183,271'Tetrazole derivatives and their use for the treatment of cardiovascular diseases'2012 8,173,665'I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use'2012 8,173,704'Difluorophenol derivatives and their use'2012 8,168,821'Cyclopropylacetic acid derivatives and use thereof'2012 8,129,378'Substituted oxazolidinones and their use in the field of blood coagulation'2012 8,101,601'Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders'2012 8,101,615'1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors'2012 8,097,629'Dihydropyridinone derivatives'2012 8,063,234'Substituted 7-sulfanylmethyl-, 7-sulfinylmethyl- and 7-sulfonylmethylindoles and the use thereof'2011 8,058,447'4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof'2011 7,998,988'Biphenyl compounds useful in the treatment or prevention of cardiovascular disorders'2011 7,989,633'4-Chromenonyl-1,4-dihydropyridines and their use'2011 7,985,876'Substituted dibenzoic acid derivatives and use thereof'2011 7,893,073'Heterocyclic derivatives'2011 7,767,702'Substituted oxazolidinones for combinational therapy'2010 7,704,999'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'2010 7,696,206'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'2010 7,691,854'Dihydropyridine derivatives for use as human neutrophil elastase inhibitors'2010 7,687,510'Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes'2010 7,592,339'Substituted oxazolidinones and their use in the field of blood coagulation'2009 7,585,860'Substituted oxazolidinones and their use in the field of blood coagulation'2009 7,582,666'Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics'2009 7,576,111'Substituted oxazolidinones and their use in the field of blood coagulation'2009 7,566,723'1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use'2009 7,498,460'Isophthalic acid derivatives'2009 7,482,472'Substituted isoindoles and their use'2009 7,314,871'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension'2008 7,230,017'Dihydropyridinone derivatives'2007 7,202,243'Substituted imidazotriazines'2007 7,199,136'1,4-dihydro-1,4-diphenylpyridine derivatives'2007 7,189,738'Substituted isoindoles and their use thereof'2007 7,157,456'Substituted oxazolidinones and their use in the field of blood coagulation'2007 7,125,995'Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)'2006 7,122,540'2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'2006 7,115,602'Heterocycles 3'2006 7,098,207'Imidazotriazinones and the use thereof'2006 7,091,203'Imidazo[1,3,5]triazinones and their use'2006 7,087,605'5-Ethyl-imidazotriazinones'2006 7,074,784'Medicaments against viral diseases'2006 7,034,017'Substituted oxazolidinones and their use in the field of blood coagulation'2006 7,022,709'Selective PDE 2 inhibitors as pharmaceuticals for improving perception'2006 6,998,402'Substituted imidazotriazinones'2006 6,984,646'Imidazopyridinones as p38 map kinase inhibitors'2006 6,943,163'7-Alkyl and cycloalkyl-substituted imidazotriazinones'2005 6,936,609'Imidazotriazines for use as phosphodiesterase inhibitors'2005 6,933,295'Substituted isoindoles and the use thereof'2005 6,930,114'Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors'2005 6,900,194'Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases'2005 6,890,922'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'2005 6,878,708'Imidazotriazinones and the use thereof'2005 6,838,459'7-alkyl-and cycloalkyl-substituted imidazotriazinones'2005 6,803,365'Imidazo1,3,5triazinones and the use thereof'2004 6,777,416'Isoxazolo pyrimidinones and the use thereof'2004 6,696,451'Dihydropyrimidines'2004 6,683,081'Triazolotriazinones and the use thereof'2004 6,677,372'N-(3-benzofuranyl)urea-derivatives'2004 6,649,618'Substituted amidoalkyl-uracils and their use'2003 6,610,687'Benzofuranylsulfonates'2003 6,589,949'3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases'2003 6,573,263'Substituted imidazotriazinones'2003 6,566,360'2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors'2003 6,476,029'7-alkyl- and cycloalkyl-substituted imidazotriazinones'2002 6,458,796'Dihydro-1,2,3triazolo-4,5-dpyrimidin-7-one'2002 6,399,657'N-(3-benzofuranyl) urea-derivatives'2002 6,362,178'2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors'2002 6,174,884'1,5-dihydro-pyrazolo[34-D]-pyrimidinone derivatives'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2008Patents assigned to BAYER AG (25)· patent assignee history

2001–2020Based in Wuppertal, DE· patent location history

2006–2016Patents assigned to SCHLEMMER KARL-HEINZ (35)· patent assignee history

2011–2020Patents assigned to Bayer Pharma AG (26)· patent assignee history

2012–2019Patents assigned to BAYER IP GMBH (31)· patent assignee history

2012–2016Patents assigned to KNORR ANDREAS (15)· patent assignee history

2014Based in Leverkusen, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
SCHLEMMER KARL-HEINZself	35	2006–2016
BAYER IP GMBH	31	2012–2019
Bayer Pharma AG	26	2011–2020
BAYER AG	25	2001–2008
KNORR ANDREAS	15	2012–2016

Locations

Location	Patents	Span
Wuppertal, DE	114	2001–2020
Leverkusen, DE	1	2014